FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048459502> ?p ?o ?g. }

• W3048459502 endingPage "1635" @default.
• W3048459502 startingPage "1630" @default.
• W3048459502 abstract "BackgroundIncreasing multidrug resistance rates in Neisseria gonorrhoeae have raised concerns and an urgent call for new antibiotics for treatment of gonorrhoea. Several decades of subdued drug development in this field and the recent failures of two new antibiotics to show non-inferiority compared with the current first-line antibiotics ceftriaxone plus azithromycin highlight the need for improved preclinical tools to predict clinical outcome of new drugs in the development process.ObjectivesTo summarize current pharmacokinetic/pharmacodynamic (PK/PD) knowledge and dose-finding strategies for antibiotics against gonorrhoea.SourcesLiterature review of published papers and discussions by global experts at a special workshop on this topic.ContentWe review current knowledge of gonococcal specific PK/PD principles and provide an update on new in vitro and in vivo models to correlate drug exposure with clinical outcome, and identify challenges and gaps in gonococcal therapeutic research.ImplicationsIdentifying the ideal antimicrobial agent and dose for treating uncomplicated urogenital and pharyngeal gonococcal disease requires appropriate validated non-clinical PK/PD models. Recent advances in adapting in vitro and in vivo models for use in gonorrhoea are an important step for enabling the development of new drugs with reduced risk of failure in Phase 3 clinical development and diminish the risk of emergence of resistance." @default.
• W3048459502 created "2020-08-18" @default.
• W3048459502 creator A5004551370 @default.
• W3048459502 creator A5012643783 @default.
• W3048459502 creator A5019102142 @default.
• W3048459502 creator A5020171248 @default.
• W3048459502 creator A5021667508 @default.
• W3048459502 creator A5032444632 @default.
• W3048459502 creator A5036512885 @default.
• W3048459502 creator A5040969629 @default.
• W3048459502 creator A5045497508 @default.
• W3048459502 creator A5050599439 @default.
• W3048459502 creator A5055688521 @default.
• W3048459502 creator A5059367411 @default.
• W3048459502 creator A5069892567 @default.
• W3048459502 creator A5072752076 @default.
• W3048459502 creator A5078573153 @default.
• W3048459502 date "2020-12-01" @default.
• W3048459502 modified "2023-09-26" @default.
• W3048459502 title "Pharmacokinetic/pharmacodynamic considerations for new and current therapeutic drugs for uncomplicated gonorrhoea—challenges and opportunities" @default.
• W3048459502 cites W1477312507 @default.
• W3048459502 cites W1764265034 @default.
• W3048459502 cites W1784196171 @default.
• W3048459502 cites W2006217231 @default.
• W3048459502 cites W2016702559 @default.
• W3048459502 cites W2030850454 @default.
• W3048459502 cites W2059757881 @default.
• W3048459502 cites W2064809559 @default.
• W3048459502 cites W2084497436 @default.
• W3048459502 cites W2093329456 @default.
• W3048459502 cites W2096099936 @default.
• W3048459502 cites W2099653793 @default.
• W3048459502 cites W2100695003 @default.
• W3048459502 cites W2101809821 @default.
• W3048459502 cites W2111222049 @default.
• W3048459502 cites W2120662592 @default.
• W3048459502 cites W2162573988 @default.
• W3048459502 cites W2162758710 @default.
• W3048459502 cites W2168110846 @default.
• W3048459502 cites W2405392974 @default.
• W3048459502 cites W2529034339 @default.
• W3048459502 cites W2570320744 @default.
• W3048459502 cites W2707873570 @default.
• W3048459502 cites W2738082276 @default.
• W3048459502 cites W2761417493 @default.
• W3048459502 cites W2779019546 @default.
• W3048459502 cites W2782538875 @default.
• W3048459502 cites W2789808681 @default.
• W3048459502 cites W2795880500 @default.
• W3048459502 cites W2801734974 @default.
• W3048459502 cites W2803660889 @default.
• W3048459502 cites W2887164040 @default.
• W3048459502 cites W2891994020 @default.
• W3048459502 cites W2899900395 @default.
• W3048459502 cites W2909738949 @default.
• W3048459502 cites W2910916379 @default.
• W3048459502 cites W2914022105 @default.
• W3048459502 cites W2919778958 @default.
• W3048459502 cites W2921923117 @default.
• W3048459502 cites W2942953505 @default.
• W3048459502 cites W2943774891 @default.
• W3048459502 cites W2950093013 @default.
• W3048459502 cites W2956411441 @default.
• W3048459502 cites W2963541510 @default.
• W3048459502 cites W2965024380 @default.
• W3048459502 cites W2969536729 @default.
• W3048459502 cites W2970824204 @default.
• W3048459502 cites W2971783272 @default.
• W3048459502 cites W2974873842 @default.
• W3048459502 cites W2991330881 @default.
• W3048459502 cites W2993301528 @default.
• W3048459502 cites W3010223436 @default.
• W3048459502 cites W4210955077 @default.
• W3048459502 doi "https://doi.org/10.1016/j.cmi.2020.08.006" @default.
• W3048459502 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32798687" @default.
• W3048459502 hasPublicationYear "2020" @default.
• W3048459502 type Work @default.
• W3048459502 sameAs 3048459502 @default.
• W3048459502 citedByCount "13" @default.
• W3048459502 countsByYear W30484595022021 @default.
• W3048459502 countsByYear W30484595022022 @default.
• W3048459502 countsByYear W30484595022023 @default.
• W3048459502 crossrefType "journal-article" @default.
• W3048459502 hasAuthorship W3048459502A5004551370 @default.
• W3048459502 hasAuthorship W3048459502A5012643783 @default.
• W3048459502 hasAuthorship W3048459502A5019102142 @default.
• W3048459502 hasAuthorship W3048459502A5020171248 @default.
• W3048459502 hasAuthorship W3048459502A5021667508 @default.
• W3048459502 hasAuthorship W3048459502A5032444632 @default.
• W3048459502 hasAuthorship W3048459502A5036512885 @default.
• W3048459502 hasAuthorship W3048459502A5040969629 @default.
• W3048459502 hasAuthorship W3048459502A5045497508 @default.
• W3048459502 hasAuthorship W3048459502A5050599439 @default.
• W3048459502 hasAuthorship W3048459502A5055688521 @default.
• W3048459502 hasAuthorship W3048459502A5059367411 @default.
• W3048459502 hasAuthorship W3048459502A5069892567 @default.
• W3048459502 hasAuthorship W3048459502A5072752076 @default.
• W3048459502 hasAuthorship W3048459502A5078573153 @default.

• next